南岸集團(00577.HK):各方擬7月21日釐定就傳票保留半天進行實質辯論聆訊日期
格隆匯7月16日丨南岸集團(00577.HK)公吿,原吿人尋求針對公司及其附屬公司頒發緊急禁制令的申請(案件編號HCA1054/2021)已於2021年7月16日上午十時正在香港高等法院吳法官席前聆訊。
在聆訊上,公司及其附屬公司反對原吿人傳票中有關尋求頒發緊急禁制令的申請。吳法官指示將傳票日期押後並保留半天進行實質辯論。
就此,訴訟各方已預約於2021年7月21日出席高等法院,以釐定就傳票保留半天進行實質辯論的聆訊日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.